Advanced Cancer Clinical Trials in Guangzhou, Guangdong
10 recruitingGuangzhou, Guangdong, China
Showing 1–10 of 10 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
Advanced CancerAdvanced Solid Tumors
Shanghai Allink Biotherapeutics Co., Ltd.202 enrolled38 locationsNCT06656390
Recruiting
Phase 2
Toripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors
Advanced CancerSolid Tumor
Sun Yat-sen University35 enrolled4 locationsNCT03810339
Recruiting
Phase 1
Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers
Advanced cancers
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.42 enrolled11 locationsNCT07260708
Recruiting
Phase 1
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Gastric CancerEsophageal AdenocarcinomaMetastatic Cancer+5 more
I-Mab Biopharma US Limited330 enrolled21 locationsNCT04900818
Recruiting
Phase 1Phase 2
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors
Advanced Cancer
Suzhou Transcenta Therapeutics Co., Ltd.320 enrolled40 locationsNCT04495296
Recruiting
Phase 1
Clinical Trial of TQB3002 in Patients With Advanced Cancers
Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.150 enrolled11 locationsNCT06662760
Recruiting
Phase 1
Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers
Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.150 enrolled17 locationsNCT06188624
Recruiting
Phase 1
A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors
Advanced cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.140 enrolled1 locationNCT06413953
Recruiting
Phase 1Phase 2
Plasmodium Immunotherapy for Advanced Cancers
Advanced cancers
CAS Lamvac Biotech Co., Ltd.20 enrolled1 locationNCT03375983
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients
Advanced Solid TumorAdvanced CancerLung Cancer, Nonsmall Cell
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.280 enrolled41 locationsNCT04237805